Form 8.3 - Udg Healthcare Plc
19 June 2021 - 12:25AM
UK Regulatory
TIDMUDG
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing Elliott Investment Management,
(Note 1) L.P
Elliott International,
L.P.
Elliott Associates, L.P.
-------------------------- ------------------------------
Company dealt in UDG Healthcare plc
-------------------------- ------------------------------
Class of relevant security Ordinary Shares: IE0033024807
to which the dealings
being disclosed relate
(Note 2)
-------------------------- ------------------------------
Date of dealing 17(th) June 2021
-------------------------- ------------------------------
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Long Short
--------------------------- -------------------- -------------
Number (%) Number (%)
--------------------------- ------------ ------ -------- ---
(1) Relevant securities
--------------------------- -------------------- -------------
(2) Derivatives (other
than options) 9,376,740 (3.722%)
--------------------------- -------------------- -------------
(3) Options and agreements
to purchase/sell
--------------------------- -------------------- -------------
Total 9,376,740 (3.722%)
--------------------------- -------------------- -------------
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: Long Short
--------------------------- -------------- ---------------
Number (%) Number (%)
--------------------------- ------- --- -------- ---
(1) Relevant securities
--------------------------- -------------- ---------------
(2) Derivatives (other
than options)
--------------------------- -------------- ---------------
(3) Options and agreements
to purchase/sell
--------------------------- -------------- ---------------
Total
--------------------------- -------------- ---------------
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
(Note 5)
-------------- ------------------------------ ---------------
(b) Derivatives transactions (other than options transactions)
Product Nature of transaction Number of relevant Price per
name, (Note 6) securities unit
e.g. CFD (Note 7) (Note 5)
----------- --------------------- ------------------ -----------
Equity Swap Increased Long 666,141 GBP10.47425
----------- --------------------- ------------------ -----------
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. American, date money paid/received
e.g. call purchasing, to which European per unit
option varying the option etc. (Note 5)
etc. relates (Note
7)
---------- ------------ -------------- -------- --------------- ------ --------------------
(ii) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note
5)
----------------- -------------------------- -------------------
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable)
(Note 5)
--------------------- ------------- --------------------
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person relating to the
voting rights of any relevant securities under any option referred
to on this form or relating to the voting rights or future
acquisition or disposal of any relevant securities to which any
derivative referred to on this form is referenced. If none, this
should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) YES/NO
Date of disclosure 18/06/2021
--------------------------- -----------------------------
Contact name Michael Cross
--------------------------- -----------------------------
Telephone number 0203 009 1306
mcross@elliottadvisors.co.uk
--------------------------- -----------------------------
If a connected EFM, name
of offeree/offeror with
which connected
--------------------------- -----------------------------
If a connected EFM, state
nature of connection (Note
10)
--------------------------- -----------------------------
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER
PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form
8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product Written, Number of relevant Exercise Type, e.g. Expiry
name, or purchased securities price American, date
e.g. call to which the (Note European
option option or derivative 2) etc.
relates
------------ --------------- --------------------- -------- ---------- ------
Notes
1. Where there are open option positions or open derivative positions
(except for CFDs), full details should be given. Full details of any
existing agreements to purchase or to sell must also be given on this
form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the
Rules. If in doubt, consult the Panel.
(END) Dow Jones Newswires
June 18, 2021 10:25 ET (14:25 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From Apr 2024 to May 2024
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From May 2023 to May 2024
